Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing

Archives of Dermatological Research

Volumn 294, Issue 7, 2002, Pages 324-330

  Huttunen, Maria ^a,b   Naukkarinen, Anita ^a   Horsmanheimo, Maija ^a   Harvima, Ilkka T ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Kit receptor; Mast cell; Stem cell factor; Wound healing

Indexed keywords

STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; FEMALE; HUMAN; HUMAN TISSUE; LEG ULCER; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PSORIASIS; SKIN BIOPSY; SKIN CELL; SKIN TRANSPLANTATION; STAINING; WOUND HEALING; BIOSYNTHESIS; CHRONIC DISEASE; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; LEG ULCER; MAST CELLS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; PSORIASIS; STEM CELL FACTOR; TIME FACTORS; WOUND HEALING;

EID: 0036402922     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-002-0331-1     Document Type: Article

References (37)

1. Baghestanian M, Agis H, Bevec D, Bankl HC, Hofbauer R, Kress HG, Butterfield JH, Muller MR, Ashman LK, Fureder W, et al (1996) Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells. Exp Hematol 24:1377-1386
2. Bolton LL, Montagna W (1993) Mast cells in human ulcers. Am J Dermatopathol 15:133-138
3. Boyd JF, Smith AN (1959) The effect of histamine and a histamine-releasing agent (compound 48/80) on wound healing. J Path Bact 78:379-388
4. Brody I (1984) Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 82:460-464
5. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM (1992) The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149:599-608
6. Dastych J, Metcalfe DD (1994) Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152:213-219
7. Dippel E, Haas N, Grabbe J, Schadendorf D, Hamann K, Czarnetzki BM (1995) Expression of the c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo. Br J Dermatol 132:182-189
8. Ghannadan M, Baghestanian M, Wimazal F, Eisenmenger M, Latal D, Kargul G, Walchshofer S, Sillaber C, Lechner K, Valent P (1998) Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 111:689-695
9. Hamann K, Grabbe J, Welker P, Haas N, Algermissen B, Czarnet-zki BM (1994) Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 286:380-385
10. Hamann K, Haas N, Grabbe J, Czarnetzki BM (1995) Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 133:203-208
11. Harvima IT, Naukkarinen A, Harvima RJ, Aalto ML, Neittaanmäki H, Horsmanheimo M (1990) Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 282:428-433
12. Harvima IT, Naukkarinen A, Paukkonen K, Harvima RJ, Aalto ML, Schwartz LB, Horsmanheimo M (1993) Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 285:184-192
13. Harvima IT, Haapanen L, Ackermann L, Naukkarinen A, Harvima RJ, Horsmanheimo M (1999) Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions. Acta Derm Venereol 79:98-104
14. Hermes B, Feldmann-Böddeker I, Welker P, Algermissen B, Steckelings MU, Grabbe J, Henz BM (2000) Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. J Invest Dermatol 114:51-55
15. Hermes B, Welker P, Feldmann-Böddeker I, Krüger-Krasagakis S, Hartmann K, Zuberbier T, Henz BM (2001) Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol 116:387-393
16. Horsmanheimo L, Harvima IT, Järvikallio A, Harvima RJ, Naukkarinen A, Horsmanheimo M (1994) Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 131:348-353
17. Huttunen M, Aalto M-L, Harvima RJ, Horsmanheimo M, Harvima IT (2000) Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Exp Dermatol 9:258-265
18. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ (1994) The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321-328
19. Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB (1992) Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009-3021
20. Kaminska R, Harvima IT, Naukkarinen A, Nilsson G, Horsmanheimo M (1996) Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection. J Pathol 180:434-440
21. Kivinen PK, Kaminska R, Naukkarinen A, Harvima RJ, Horsmanheimo M, Harvima IT (2001) Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells. Exp Dermatol 10:246-255
22. Kivinen PK, Nilsson G, Naukkarinen A, Harvima IT (2002) Mast cell survival and apoptosis in organ-cultured human skin. Exp Dermatol (in press)
23. Longley BJ Jr, Morganroth GS, Tyrrell L, Tie Gang Ding, Anderson DM, Williams DE, Halaban R (1993) Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302-1307
24. Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, Schechter NM (1997) Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci U S A 94:9017-9021
25. Mitsui H, Furitsu T, Dvorak AM, Irani AM, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S, et al (1993) Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A 90:735-739
26. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A (1994a) Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153:3717-3723
27. Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani AM, Schwartz LB (1994b) Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84: 1519-1527
28. Persinger MA, Lepage P, Simard JP, Parker GH (1983) Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 108:179-187
29. Petersen LJ, Hansen U, Kristensen JK, Nielsen H, Skov PS, Nielsen HJ (1998) Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm Venereol 78: 190-193
30. Reich JD, Cazzaniga AL, Mertz PM, Kerdel FA, Eaglstein WH (1991) The effect of electrical stimulation on the number of mast cells in healing wounds. J Am Acad Dermatol 25:40-46
31. Shimizu Y, Ashman LK, Du Z, Schwartz LB (1996) Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit. J Immunol 156:3443-3449
32. Valent P, Spanblochl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K (1992) Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237-2245
33. Weiss RR, Whitaker-Menezes D, Longley J, Bender J, Murphy GF (1995) Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 104:101-106
34. Welker P, Grabbe J, Zuberbier T, Grutzkau A, Henz BM (2001) GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res 293:249-258
35. Wichmann BE (1955) The mast cell count during the process of wound healing. Acta Pathol Microbiol Scand [Suppl] 108
36. Zhang S, Anderson DF, Bradding P, Coward WR, Baddeley SM, MacLeod JD, McGill JI, Church MK, Holgate ST, Roche WR (1998) Human mast cells express stem cell factor. J Pathol 186:59-66
37. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VF, Birkett NC, Williams LR, et al (1990) Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195-201